AstraZeneca Asserts Seroquel Patent Against Teva

Law360, New York (June 29, 2007, 12:00 AM EDT) -- AstraZeneca Pharmaceuticals filed a lawsuit against Teva Pharmaceutical Industries Ltd. in a New Jersey court Thursday over a patent for AstraZeneca's multibillion-dollar anti-psychotic drug Seroquel.

AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP filed the lawsuit in the U.S. District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA Inc.

At issue in the suit is U.S. Patent Number 4,879,288, entitled “Novel Dibenzothiazepine Antipsychotic,” held by AstraZeneca Pharmaceuticals. The '288 patent had been slated to expire on March 20, 2007,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.